| Date | Title | Description | Source |
| 12.03.2024 | KECK GRADUATE INSTITUTE SELECTS DR. MOHAMED ABOUSALEM AS ITS... | Dr. Abousalem succeeds Dr. Sheldon Schuster, KGI's president since 2003.
Claremont, CA, March 12, 20... | einpresswi... |
| 13.11.2023 | Ray Therapeutics secures $4M from CIRM to develop optogeneti... | Age-related macular degeneration (AMD) is a prevalent cause of vision loss among individuals over th... | techstartu... |
| 18.08.2020 | How do you separate scientifically sound stem cell therapies... | For patients who’ve run out of other options, experimental, unproven therapies like stem cell treatm... | statnews.c... |
| 23.12.2019 | To make advanced therapies, we need to industrialize persona... | What’s the best way to measure the real rate of progress in personalized cell therapies, gene therap... | statnews.c... |
| 24.09.2019 | Kudos to Google for banning stem cell ads. Other tech compan... | Google took an important step this month toward restricting the reach of one breed of 21st-century s... | statnews.c... |
| 28.02.2019 | Scripps Research explores new model to advance drug developm... | “We wanted to build a new model,” said Schultz in a conference call, “that more effectively bridges ... | medcitynew... |
| 20.07.2018 | Dr. rahhal co-authors breakthrough stem cell Transplant tria... | Over the last several months the press has been abuzz with the promising results of two recent, unre... | exsightven... |
| 18.10.2017 | Google’s GV and allies double down on Forty Seven with th... | One of the most advanced, well-financed biotechs in the Bay Area just landed a $75 million B rou... | endpts.com... |
| 29.09.2017 | Chris Carpenter joins the R&D exodus out of pharma;... | ⇨ After spending the last decade in Big Pharma R&D, Chris Carpenter is making the leap to ... | endpts.com... |
| 05.07.2017 | SanBio Receives $20M Grant from CIRM | SanBio, Inc., a Tokyo, Japan, and Mountain View, California-based scientific leader in regenerative ... | finsmes.co... |
| 26.04.2017 | Cancer-causing DNA is found in some stem cells being used in... | Some human stem cells growing in labs that researchers have used in experiments to treat serious dis... | statnews.c... |
| 27.03.2017 | Novartis research leader takes the helm at Forty Seven, ... | Menlo Park, CA-based Forty Seven launched well ahead of the game compared to most any other biot... | endpts.com... |
| 13.06.2016 | AiVita raises $2M for ovarian cancer immunotherapy treatment | AiVita is also investigating a treatment for age-related macular degeneration (AMD), using pluripote... | medcitynew... |
| 22.12.2008 | VistaGen gobbles up $1M for stem-cell research | South San Francisco-based biotech firm VistaGen Therapeutics raised $1 million in grant funding from... | venturebea... |
| 16.09.2007 | Troubled stem-cell institute finally gets new leader | California’s $3 billion stem-cell agency, which has been without a permanent leader since the end of... | venturebea... |
| 15.09.2007 | Stem-cell institute gets a new president, but its management... | California’s $3 billion stem-cell agency, which has been without a permanent leader since the end of... | venturebea... |
| 30.08.2007 | California’s stem-cell management disarray | (CORRECTED: See below.)
These should be the best of times for California’s $3 billion stem-cell prog... | venturebea... |
| 19.08.2007 | Personal-genetics startup Navigenics, a competitor to Google... | (UPDATED: See below.)
Navigenics, a new personal genetics startup with some serious backing, threw b... | venturebea... |
| 01.08.2007 | Genoptix files $86M IPO for diagnostic services | Genoptix, a Carlsbad, Calif., provider of diagnostic services to cancer and blood-disease specialist... | venturebea... |
| 17.05.2007 | Legal cloud lifts from California stem-cell effort | The California Supreme Court swept away the last legal impediment to the state’s $3 billion stem-cel... | venturebea... |
| 10.05.2007 | Roundup: Anemia drugs under assault, stem-cell trial moves f... | Is the bell tolling for EPO? — The news keeps going from bad to worse for the wonder drugs of biotec... | venturebea... |
| 09.05.2007 | Massachusetts jumps on the stem-cell bandwagon | (UPDATE: Minor editing.)
Massachusetts may soon be the next state to offer direct support for stem-c... | venturebea... |
| 21.04.2007 | Health and science roundup: Amgen, generic biologics, the or... | Amgen’s anemia rollercoaster — Biotechnology titan Amgen may have dodged a bullet when a study relea... | venturebea... |
| 21.04.2007 | Health and science roundup: Amgen, generic biologics, the or... | (Note: This item has been copied over to the Life Sciences page from its original location on the Ve... | venturebea... |
| 01.08.2006 | Stem-cell institute: Will it choose transparency or not? | SF Sentinel
Tomorrow, the state’s troubled $3 billion stem-cell institute will decide whether member... | venturebea... |
| - | AiVita raises $2M for ovarian cancer immunotherapy treatment | Regenerative medicine startup AiVita Biomedical has raised $2 million in series A financing from Cal... | medcitynew... |
| - | Scripps Research explores new model to advance drug developm... | Scripps Research president and CEO Peter Schultz discusses new funding models at the Spectrum meetin... | medcitynew... |
